InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

SciGen Limited (ASX: SIE) - Announcements

DELISTED - Current share price for SIE : $0.068

ASX company news and announcements for SciGen Limited (SIE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SciGen Limited (SIE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SciGen Limited (SIE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SciGen Limited (SIE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Acquires manufacturing facility from Shreya Biotech 5 Apr 2006 11:49AM $0.072 $0.068 fallen by 5.56%
- Signs collaborative agreement with OctoPlus 9 Mar 2006 8:30AM $0.081 $0.068 fallen by 16.05%
- Mandatory Conditional Offer by Bioton 6 Mar 2006 8:30AM $0.088 $0.068 fallen by 22.73%
- Half Yearly Report & Half Year Accounts 27 Feb 2006 8:30AM $0.080 $0.068 fallen by 15%
- Commitments Test Entity - Second Quarter Report 31 Jan 2006 12:35PM $0.090 $0.068 fallen by 24.44%
- Mandatory Conditional Offer for Scigen Ltd by Bioton SA 24 Jan 2006 9:07AM $0.091 $0.068 fallen by 25.27%
- To establish manufacturing facility in China 13 Dec 2005 1:34PM $0.088 $0.068 fallen by 22.73%
- Market Update: Acquisition Offer by Bioton 6 Dec 2005 10:05AM $0.088 $0.068 fallen by 22.73%
- Trading Halt 5 Dec 2005 12:22PM $0.072 $0.068 fallen by 5.56%
- Insulin registered in Thailand 14 Nov 2005 8:32AM $0.073 $0.068 fallen by 6.85%
- Share Exchange Agreement 31 Oct 2005 9:29AM $0.074 $0.068 fallen by 8.11%
- Commitments Test Entity - First Quarter Report 27 Oct 2005 8:29AM $0.065 $0.068 risen by 4.62%
- Further Info on the HBV Distribution Agmt in China 13 Oct 2005 8:30AM $0.084 $0.068 fallen by 19.05%
- Signs US$145m distribution agreement 10 Oct 2005 8:31AM $0.098 $0.068 fallen by 30.61%
- Preliminary Final Report 29 Aug 2005 9:39AM $0.046 $0.068 risen by 47.83%
- Delay in Insulin Registration in Bangladesh 3 Aug 2005 10:27AM $0.044 $0.068 risen by 54.55%
- Commitments Test Entity - Fourth Quarter Report 29 Jul 2005 3:47PM $0.046 $0.068 risen by 47.83%
- Insulin commercialisation agreement for Bangladesh 21 Jun 2005 9:21AM $0.044 $0.068 risen by 54.55%
- Insulin Sales to Commence in Sri Lanka 1 Jun 2005 3:03PM $0.050 $0.068 risen by 36%
- Fast tracking hepatitis B vaccine production 18 Apr 2005 11:51AM $0.045 $0.068 risen by 51.11%
- Insulin registered in Philippines 17 Feb 2005 9:46AM $0.053 $0.068 risen by 28.30%
- Hepatitis B vaccine enters European market 15 Feb 2005 10:43AM $0.056 $0.068 risen by 21.43%
- Trading Halt 31 Jan 2005 10:10AM n/a $0.068 n/a
- Potential Strategic Investment in SciGen 29 Jun 2004 10:56AM $0.060 $0.068 risen by 13.33%
- To manufacture Hep B Vaccine and increase market coverage 11 Jun 2004 9:36AM $0.065 $0.068 risen by 4.62%

201 - 225 of 239 results

Page 9 of 10

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.